News Diabetic Macular Edema: Pricey Option May Be Cost-Effective by Medscape • 2012/08/03 • 0 Comments It may be cost-effective to treat patients who have DME with a monoclonal antibody that reduces edema and, along with deferred laser, yields crisper vision, despite the $19,216 in additional cost. Medscape Medical News Full Story →